Package 46708-349-31

{"route": ["ORAL"], "spl_id": "d9c1cc75-4e3d-4eaf-87c5-d5942a843818", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0346708349318"], "unii": ["O3FX965V0I"], "rxcui": ["562524"], "spl_set_id": ["d9c1cc75-4e3d-4eaf-87c5-d5942a843818"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-349-31)", "package_ndc": "46708-349-31", "marketing_start_date": "20190220"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-349-91)", "package_ndc": "46708-349-91", "marketing_start_date": "20190220"}], "brand_name": "Acetazolamide", "product_id": "46708-349_d9c1cc75-4e3d-4eaf-87c5-d5942a843818", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "46708-349", "generic_name": "Acetazolamide", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "500 mg/1"}], "application_number": "ANDA210423", "marketing_category": "ANDA", "marketing_start_date": "20190220", "listing_expiration_date": "20261231"}